Immune-Mediated CNS Damage

  • Katrin Kierdorf
  • Yiner Wang
  • Harald Neumann
Part of the Results and Problems in Cell Differentiation book series (RESULTS, volume 51)


Multiple sclerosis (MS) is a demyelinating autoimmune disease. However, the persisting neurological deficits in MS patients result from acute axonal injury and chronic neurodegeneration, which are both triggered by the autoreactive immune response. Innate immunity, mainly mediated by activated microglial cells and invading macrophages, appears to contribute to chronic neurodegeneration. Activated microglia produce several reactive oxygen species and proinflammatory cytokines which affect neuronal function, integrity and survival. Adaptive immunity, particularly in cytotoxic CD8+ T cells, participates in acute demyelination and axonal injury by directly attacking oligodendrocytes and possibly neurons as well. Understanding the mechanisms of immune-mediated neuronal damage might help to design novel therapy strategies for MS.


Multiple Sclerosis Experimental Autoimmune Encephalomyelitis Multiple Sclerosis Patient Major Histocompatibility Complex Class NADPH Oxidase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The group of H.N. is supported by the Hertie Foundation, the Rose Foundation, the Deutsche Forschungsgemeinschaft and the European Union (LSHM-CT-2005–018637). The Neural Regeneration Group at the University Hospital Bonn is supported by the Hertie-Foundation, the Walter-und-Ilse-Rose-Foundation, the DFG (KFO177, SFB704) and the EU (LSHM-CT-2005-018637).


  1. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783–801PubMedGoogle Scholar
  2. Alarcon R, Fuenzalida C, Santibanez M,von Bernhardi R (2005) Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid. J Biol Chem 280:30406–30415PubMedGoogle Scholar
  3. Alt C, Laschinger M, Engelhardt B (2002) Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis. Eur J Immunol 32:2133–2144PubMedGoogle Scholar
  4. Aravalli RN, Hu S, Rowen TN, Palmquist JM, Lokensgard JR (2005) Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J Immunol 175:4189–4193PubMedGoogle Scholar
  5. Archelos JJ, Previtali SC, Hartung HP (1999) The role of integrins in immune-mediated diseases of the nervous system. Trends Neurosci 22:30–38PubMedGoogle Scholar
  6. Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, Friese M, Schroder R, Deckert M, Schmidt S et al (2000) Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 192:393–404PubMedCentralPubMedGoogle Scholar
  7. Babior BM (2000) Phagocytes and oxidative stress. Am J Med 109:33–44PubMedGoogle Scholar
  8. Becher B, Durell BG, Miga AV, Hickey WF, Noelle RJ (2001) The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J Exp Med 193:967–974PubMedCentralPubMedGoogle Scholar
  9. Becher B, Bechmann I, Greter M (2006) Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J Mol Med 84:532–543PubMedGoogle Scholar
  10. Bergmann CC, Yao Q, Stohlman SA (1999) Microglia exhibit clonal variability in eliciting cytotoxic T lymphocyte responses independent of class I expression. Cell Immunol 198:44–53PubMedGoogle Scholar
  11. Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57–69PubMedGoogle Scholar
  12. Booss J, Esiri MM, Tourtellotte WW, Mason DY (1983) Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci 62:219–232PubMedGoogle Scholar
  13. Bsibsi M, Ravid R, Gveric D, van Noort JM (2002) Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 61:1013–1021PubMedGoogle Scholar
  14. Buechler C, Ritter M, Quoc CD, Agildere A, Schmitz G (1999) Lipopolysaccharide inhibits the expression of the scavenger receptor Cla-1 in human monocytes and macrophages. Biochem Biophys Res Commun 262:251–254PubMedGoogle Scholar
  15. Bullard DC, Hu X, Schoeb TR, Axtell RC, Raman C, Barnum SR (2005) Critical requirement of CD11b (Mac-1) on T cells and accessory cells for development of experimental autoimmune encephalomyelitis. J Immunol 175:6327–6333PubMedGoogle Scholar
  16. Campbell JJ, Bowman EP, Murphy K, Youngman KR, Siani MA, Thompson DA, Wu L, Zlotnik A, Butcher EC (1998) 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7. J Cell Biol 141:1053–1059PubMedCentralPubMedGoogle Scholar
  17. Carson MJ, Sutcliffe JG, Campbell IL (1999) Microglia stimulate naive T-cell differentiation without stimulating T-cell proliferation. J Neurosci Res 55:127–134PubMedGoogle Scholar
  18. Cho BP, Song DY, Sugama S, Shin DH, Shimizu Y, Kim SS, Kim YS, Joh TH (2006) Pathological dynamics of activated microglia following medial forebrain bundle transection. Glia 53:92–102PubMedGoogle Scholar
  19. Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ (2006) Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25:417–428PubMedGoogle Scholar
  20. Christie RH, Freeman M, Hyman BT (1996) Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer’s disease. Am J Pathol 148:399–403PubMedCentralPubMedGoogle Scholar
  21. Colton CA, Gilbert DL (1987) Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett 223:284–288PubMedGoogle Scholar
  22. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8:752–758PubMedGoogle Scholar
  23. de Vos AF, van Meurs M, Brok HP, Boven LA, Hintzen RQ, van der Valk P, Ravid R, Rensing S, Boon L, t Hart BA, Laman JD (2002) Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J Immunol 169:5415–5423PubMedGoogle Scholar
  24. Drapier JC, Hibbs JB Jr (1988) Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J Immunol 140:2829–2838PubMedGoogle Scholar
  25. El-Benna J, Dang PM, Gougerot-Pocidalo MA, Elbim C (2005) Phagocyte NADPH oxidase: a multicomponent enzyme essential for host defenses. Arch Immunol Ther Exp (Warsz) 53:199–206Google Scholar
  26. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207–2216PubMedGoogle Scholar
  27. Fetler L, Amigorena S (2005) Neuroscience. Brain under surveillance: the microglia patrol. Science 309:392–393PubMedGoogle Scholar
  28. Gerritse K, Laman JD, Noelle RJ, Aruffo A, Ledbetter JA, Boersma WJ, Claassen E (1996) CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A 93:2499–2504PubMedCentralPubMedGoogle Scholar
  29. Glezer I, Lapointe A, Rivest S (2006) Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries. FASEB J 20:750–752PubMedGoogle Scholar
  30. Gold R, Schmied M, Tontsch U, Hartung HP, Wekerle H, Toyka KV, Lassmann H (1996) Antigen presentation by astrocytes primes rat T lymphocytes for apoptotic cell death. A model for T-cell apoptosis in vivo. Brain 119(Pt 2):651–659PubMedGoogle Scholar
  31. Goldstein JL, Brown MS, Krieger M, Anderson RG, Mintz B (1979) Demonstration of low density lipoprotein receptors in mouse teratocarcinoma stem cells and description of a method for producing receptor-deficient mutant mice. Proc Natl Acad Sci U S A 76:2843–2847PubMedCentralPubMedGoogle Scholar
  32. Granucci F, Petralia F, Urbano M, Citterio S, Di Tota F, Santambrogio L, Ricciardi-Castagnoli P (2003) The scavenger receptor MARCO mediates cytoskeleton rearrangements in dendritic cells and microglia. Blood 102:2940–2947PubMedGoogle Scholar
  33. Grenier Y, Ruijs TC, Robitaille Y, Olivier A, Antel JP (1989) Immunohistochemical studies of adult human glial cells. J Neuroimmunol 21:103–115PubMedGoogle Scholar
  34. Greter M, Heppner FL, Lemos MP, Odermatt BM, Goebels N, Laufer T, Noelle RJ, Becher B (2005) Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med 11:328–334PubMedGoogle Scholar
  35. Harry GJ, McPherson CA, Wine RN, Atkinson K, Lefebvre d’Hellencourt C (2004) Trimethyltin-induced neurogenesis in the murine hippocampus. Neurotox Res 5:623–627PubMedCentralPubMedGoogle Scholar
  36. Havenith CE, Askew D, Walker WS (1998) Mouse resident microglia: isolation and characterization of immunoregulatory properties with naive CD4 + and CD8 + T-cells. Glia 22:348–359PubMedGoogle Scholar
  37. Hofman FM, Hinton DR, Johnson K, Merrill JE (1989) Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170:607–612PubMedGoogle Scholar
  38. Huber JD, Egleton, RD, Davis, TP (2001) Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 24:719–725PubMedGoogle Scholar
  39. Huseby ES, Liggitt D, Brabb T, Schnabel B, Ohlen C, Goverman J (2001) A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med 194:669–676PubMedCentralPubMedGoogle Scholar
  40. Husemann J, Silverstein SC (2001) Expression of scavenger receptor class B, type I, by astrocytes and vascular smooth muscle cells in normal adult mouse and human brain and in Alzheimer’s disease brain. Am J Pathol 158:825–832PubMedCentralPubMedGoogle Scholar
  41. Husemann J, Loike JD, Anankov R, Febbraio M, Silverstein SC (2002) Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 40:195–205PubMedGoogle Scholar
  42. Iliev AI, Stringaris AK, Nau R, Neumann H (2004) Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9). FASEB J 18:412–414PubMedGoogle Scholar
  43. Inohara N, Koseki T, del Peso L, Hu Y, Yee C, Chen S, Carrio R, Merino J, Liu D, Ni J, Nunez G (1999) Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J Biol Chem 274:14560–14567PubMedGoogle Scholar
  44. Jin S, Kawanokuchi J, Mizuno T, Wang J, Sonobe Y, Takeuchi H, Suzumura A (2007) Interferon-beta is neuroprotective against the toxicity induced by activated microglia. Brain Res 1179:140–146PubMedGoogle Scholar
  45. Jou I, Lee JH, Park SY, Yoon HJ, Joe EH, Park EJ (2006) Gangliosides trigger inflammatory responses via TLR4 in brain glia. Am J Pathol 168:1619–1630PubMedCentralPubMedGoogle Scholar
  46. Kanneganti TD, Lamkanfi M, Nunez G (2007) Intracellular NOD-like receptors in host defense and disease. Immunity 27:549–559PubMedGoogle Scholar
  47. Karin M, Lawrence T, Nizet V (2006) Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124:823–835PubMedGoogle Scholar
  48. Kawai T, Akira S (2007) Antiviral signaling through pattern recognition receptors. J Biochem 141:137–145PubMedGoogle Scholar
  49. Kawakami N, Nagerl UV, Odoardi F, Bonhoeffer T, Wekerle H, Flugel A (2005) Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion. J Exp Med 201:1805–1814PubMedCentralPubMedGoogle Scholar
  50. Kishida KT, Klann E (2007) Sources and targets of reactive oxygen species in synaptic plasticity and memory. Antioxid Redox Signal 9:233–244PubMedCentralPubMedGoogle Scholar
  51. Kishida KT, Pao M, Holland SM, Klann E (2005) NADPH oxidase is required for NMDA receptor-dependent activation of ERK in hippocampal area CA1. J Neurochem 94:299–306PubMedCentralPubMedGoogle Scholar
  52. Koprowski H, Zheng YM, Heber-Katz E, Fraser N, Rorke L, Fu ZF, Hanlon C, Dietzschold B (1993) In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci U S A 90:3024–3027PubMedCentralPubMedGoogle Scholar
  53. Kraal G, van der Laan LJ, Elomaa O, Tryggvason K (2000) The macrophage receptor MARCO. Microbes Infect 2:313–316PubMedGoogle Scholar
  54. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW (1993) Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol 150:2659–2667PubMedGoogle Scholar
  55. Li J, Baud O, Vartanian T, Volpe JJ, Rosenberg PA (2005) Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci U S A 102:9936–9941PubMedCentralPubMedGoogle Scholar
  56. Liao H, Bu WY, Wang TH, Ahmed S, Xiao ZC (2005) Tenascin-R plays a role in neuroprotection via its distinct domains that coordinate to modulate the microglia function. J Biol Chem 280:8316–8323PubMedGoogle Scholar
  57. Lindsey JW, Hodgkinson S, Mehta R, Siegel RC, Mitchell DJ, Lim M, Piercy C, Tram T, Dorfman L, Enzmann D et al (1994) Phase 1 clinical trial of chimeric monoclonal anti-CD4 antibody in multiple sclerosis. Neurology 44:413–419PubMedGoogle Scholar
  58. Liu B, Gao HM, Wang JY, Jeohn GH, Cooper CL, Hong JS (2002) Role of nitric oxide in inflammation-mediated neurodegeneration. Ann N Y Acad Sci 962:318–331PubMedGoogle Scholar
  59. Liu Y, Hao W, Letiembre M, Walter S, Kulanga M, Neumann H, Fassbender K (2006) Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species. J Neurosci 26:12904–12913PubMedGoogle Scholar
  60. Lowenstein PR (2002) Immunology of viral-vector-mediated gene transfer into the brain: an evolutionary and developmental perspective. Trends Immunol 23:23–30PubMedGoogle Scholar
  61. Lue LF, Walker DG, Brachova L, Beach TG, Rogers J, Schmidt AM, Stern DM, Yan SD (2001) Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer’s disease: identification of a cellular activation mechanism. Exp Neurol 171:29–45PubMedGoogle Scholar
  62. MacMicking JD, Willenborg DO, Weidemann MJ, Rockett KA, Cowden WB (1992) Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells. J Exp Med 176:303–307PubMedGoogle Scholar
  63. Marin-Teva JL, Dusart I, Colin C, Gervais A, van Rooijen N, Mallat M (2004) Microglia promote the death of developing Purkinje cells. Neuron 41:535–547PubMedGoogle Scholar
  64. Martin DE, Chiu FJ, Gigli I, Muller-Eberhard HJ (1987) Killing of human melanoma cells by the membrane attack complex of human complement as a function of its molecular composition. J Clin Invest 80:226–233PubMedCentralPubMedGoogle Scholar
  65. Mautino G, Paul-Eugene N, Chanez P, Vignola AM, Kolb JP, Bousquet J, Dugas B (1994) Heterogeneous spontaneous and interleukin-4-induced nitric oxide production by human monocytes. J Leukoc Biol 56:15–20PubMedGoogle Scholar
  66. McMahon EJ, Bailey SL, Castenada CV, Waldner H, Miller SD (2005) Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 11:335–339PubMedGoogle Scholar
  67. McVicar DW, Taylor LS, Gosselin P, Willette-Brown J, Mikhael AI, Geahlen RL, Nakamura MC, Linnemeyer P, Seaman WE, Anderson SK et al (1998) DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase. J Biol Chem 273:32934–32942PubMedGoogle Scholar
  68. Medana IM, Gallimore A, Oxenius A, Martinic MM, Wekerle H, Neumann H (2000) MHC class I-restricted killing of neurons by virus-specific CD8 + T lymphocytes is effected through the Fas/FasL, but not the perforin pathway. Eur J Immunol 30:3623–3633PubMedGoogle Scholar
  69. Medana I, Li Z, Flugel A, Tschopp J, Wekerle H, Neumann H (2001) Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity. J Immunol 167:674–681PubMedGoogle Scholar
  70. Melchjorsen J, Jensen SB, Malmgaard L, Rasmussen SB, Weber F, Bowie AG, Matikainen S, Paludan SR (2005) Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner. J Virol 79:12944–12951PubMedCentralPubMedGoogle Scholar
  71. Merrill JE (1991) Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. J Immunother 12:167–170Google Scholar
  72. Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch UK, Mack M, Heikenwalder M, Bruck W, Priller J, Prinz M (2007) Microglia in the adult brain arise from Ly-6ChiCCR2 + monocytes only under defined host conditions. Nat Neurosci 10:1544–1553PubMedGoogle Scholar
  73. Morgan SC, Taylor DL, Pocock JM (2004) Microglia release activators of neuronal proliferation mediated by activation of mitogen-activated protein kinase, phosphatidylinositol-3-kinase/Akt and delta-Notch signalling cascades. J Neurochem 90:89–101PubMedGoogle Scholar
  74. Muller FJ, Snyder EY, Loring JF (2006) Gene therapy: can neural stem cells deliver? Nat Rev Neurosci 7:75–84PubMedGoogle Scholar
  75. Neumann H (2001) Control of glial immune function by neurons. Glia 36:191–199PubMedGoogle Scholar
  76. Neumann H, Cavalie A, Jenne DE, Wekerle H (1995) Induction of MHC class I genes in neurons. Science 269:549–552PubMedGoogle Scholar
  77. Neumann H, Schmidt H, Cavalie A, Jenne D, Wekerle H (1997) Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-g and tumor necrosis factor (TNF)-a. J Exp Med 185:305–316PubMedCentralPubMedGoogle Scholar
  78. Neumann J, Gunzer M, Gutzeit HO, Ullrich O, Reymann KG, Dinkel K (2006) Microglia provide neuroprotection after ischemia. FASEB J 20:714–716PubMedGoogle Scholar
  79. Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314–1318PubMedGoogle Scholar
  80. Oehmichen W, Gencic M (1975) Experimental studies on kinetics and functions of monuclear phagozytes of the central nervous system. Acta Neuropathol Suppl (Suppl 6):285–290Google Scholar
  81. Olofsson P, Holmberg J, Tordsson J, Lu S, Akerstrom B, Holmdahl R (2003) Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet 33:25–32PubMedGoogle Scholar
  82. Paresce DM, Ghosh RN, Maxfield FR (1996) Microglial cells internalize aggregates of the Alzheimer’s disease amyloid beta-protein via a scavenger receptor. Neuron 17:553–565PubMedGoogle Scholar
  83. Prinz M, Garbe F, Schmidt H, Mildner A, Gutcher I, Wolter K, Piesche M, Schroers R, Weiss E, Kirschning CJ et al (2006) Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest 116:456–464PubMedCentralPubMedGoogle Scholar
  84. Qin H, Wilson CA, Roberts KL, Baker BJ, Zhao X, Benveniste EN (2006) IL-10 inhibits lipopolysaccharide-induced CD40 gene expression through induction of suppressor of cytokine signaling-3. J Immunol 177:7761–7771PubMedGoogle Scholar
  85. Radi R, Beckman JS, Bush KM, Freeman BA (1991) Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 266:4244–4250PubMedGoogle Scholar
  86. Raivich G (2005) Like cops on the beat: the active role of resting microglia. Trends Neurosci 28:571–573PubMedGoogle Scholar
  87. Ransohoff RM (2007) Microgliosis: the questions shape the answers. Nat Neurosci 10:1507–1509PubMedGoogle Scholar
  88. Remington LT, Babcock AA, Zehntner SP, Owens T (2007) Microglial recruitment, activation, and proliferation in response to primary demyelination. Am J Pathol 170:1713–1724PubMedCentralPubMedGoogle Scholar
  89. Sawada M, Kondo N, Suzumura A, Marunouchi T (1989) Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res 491:394–397PubMedGoogle Scholar
  90. Schmid CD, Sautkulis LN, Danielson PE, Cooper J, Hasel KW, Hilbush BS, Sutcliffe JG, Carson MJ (2002) Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia. J Neurochem 83:1309–1320PubMedCentralPubMedGoogle Scholar
  91. Siegel RM, Chan FK, Chun HJ, Lenardo MJ (2000) The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol 1:469–474PubMedGoogle Scholar
  92. Streit WJ (2002) Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40:133–139PubMedGoogle Scholar
  93. Takahashi K, Rochford CD, Neumann H (2005) Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 201:647–657PubMedCentralPubMedGoogle Scholar
  94. Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H (2007) TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med 4:e124PubMedCentralPubMedGoogle Scholar
  95. Town T, Jeng D, Alexopoulou L, Tan J, Flavell RA (2006) Microglia recognize double-stranded RNA via TLR3. J Immunol 176:3804–3812PubMedGoogle Scholar
  96. Traugott U (1983) Acute experimental autoimmune encephalomyelitis. Differences between T cell subsets in the blood and meningeal infiltrates in susceptible and resistant strains of guinea pigs. J Neurol Sci 61:81–91PubMedGoogle Scholar
  97. Trowsdale J, Barten R, Haude A, Stewart CA, Beck S, Wilson MJ (2001) The genomic context of natural killer receptor extended gene families. Immunol Rev 181:20–38PubMedGoogle Scholar
  98. Turnbull IR, Gilfillan S, Cella M, Aoshi T, Miller M, Piccio L, Hernandez M, Colonna M (2006) Cutting edge: TREM-2 attenuates macrophage activation. J Immunol 177:3520–3524PubMedGoogle Scholar
  99. van der Laan LJ, Ruuls SR, Weber KS, Lodder IJ, Dopp EA, Dijkstra CD (1996) Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide. J Neuroimmunol 70:145–152PubMedGoogle Scholar
  100. van Kooten C, Banchereau J (2000) CD40-CD40 ligand. J Leukoc Biol 67:2–17PubMedGoogle Scholar
  101. Visser L, Jan de Heer H, Boven LA, van Riel D, van Meurs M, Melief MJ, Zahringer U, van Strijp J, Lambrecht BN, Nieuwenhuis EE, Laman JD (2005) Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease. J Immunol 174:808–816PubMedGoogle Scholar
  102. Visser L, Melief MJ, van Riel D, van Meurs M, Sick EA, Inamura S, Bajramovic JJ, Amor S, Hintzen RQ, Boven LA et al (2006) Phagocytes containing a disease-promoting Toll-like receptor/Nod ligand are present in the brain during demyelinating disease in primates. Am J Pathol 169:1671–1685PubMedCentralPubMedGoogle Scholar
  103. Vodovotz Y, Bogdan C (1994) Control of nitric oxide synthase expression by transforming growth factor-beta: implications for homeostasis. Prog Growth Factor Res 5:341–351PubMedGoogle Scholar
  104. Walter S, Letiembre M, Liu Y, Heine H, Penke B, Hao W, Bode B, Manietta N, Walter J, Schulz-Schuffer W, Fassbender K (2007) Role of the toll-like receptor 4 in neuroinflammation in Alzheimer’s disease. Cell Physiol Biochem 20:947–956PubMedGoogle Scholar
  105. Walton NM, Sutter BM, Laywell ED, Levkoff LH, Kearns SM, Marshall GP II, Scheffler B, Steindler DA (2006) Microglia instruct subventricular zone neurogenesis. Glia 54:815–825PubMedGoogle Scholar
  106. Williams K, Ulvestad E, Waage A, Antel JP, McLaurin J (1994) Activation of adult human derived microglia by myelin phagocytosis in vitro. J Neurosci Res 38:433–443PubMedGoogle Scholar
  107. Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula TA, Koch WH, Andrews AW, Allen JS et al (1991) DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254:1001–1003PubMedGoogle Scholar
  108. Yamada Y, Doi T, Hamakubo T, Kodama T (1998) Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the central nervous system. Cell Mol Life Sci 54:628–640PubMedGoogle Scholar
  109. Zamvil SS, Steinman L (1990) The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 8:579–621PubMedGoogle Scholar
  110. Zekki H, Feinstein DL, Rivest S (2002) The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS. Brain Pathol 12:308–319PubMedGoogle Scholar
  111. Ziv Y, Ron N, Butovsky O, Landa G, Sudai E, Greenberg N, Cohen H, Kipnis J, Schwartz M (2006) Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci 9:268–275PubMedGoogle Scholar

Copyright information

© Springer Berlin Heidelberg 2009

Authors and Affiliations

  1. 1.Institute of Reconstructive NeurobiologyUniversity Bonn LIFE and BRAIN Center, University Bonn and Hertie-FoundationBonnGermany

Personalised recommendations